Licensing deal with Novartis SAJA announced signing a contract on 15th December 2015 at SAJA headquarter with Novartis AG to launch SAJA first anti diabetic drug (Jalra® and Jalra M®)  as a [...]

SAJA plant Expansion phase shall end up in the first quarter 2017; This strategic expansion is going to leverage SAJA capabilities in the pharma products production as well as the secondary and [...]

Licensing and manufacturing cooperation with Sanofi SAJA announced signing a contract in December 2015 with Sanofi to launch the premium anti diabetic drug (Vivaro ®)  as a second brand  of [...]